Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13721525 | 0.95 | TRPA1 (0.58) | TRPA1TSHREPHX1CYP1A2ALPI | |
| Acetic Acid SCHEMBL10433402 | 0.89 | ALPI (0.53) | TRPA1TSHRCYP1A2ALPIPKM | |
| SCHEMBL11746759 | 0.87 | TRPA1 (0.47) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL6427170 | 0.86 | TRPA1 (0.50) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL28443386 | 0.86 | ANPEP (0.52) | TRPA1TSHREPHX1CYP1A2IDO1 | |
| SCHEMBL7906029 | 0.86 | TRPA1 (0.50) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL353179 | 0.86 | TRPA1 (0.50) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL29822049 | 0.86 | TRPA1 (0.50) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL28573244 | 0.86 | TRPA1 (0.50) | TRPA1TSHREPHX1CYP1A2ALPI | |
| SCHEMBL2604925 | 0.86 | TRPA1 (0.55) | TRPA1TSHREPHX1CYP1A2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638553-A1 | BPA-FREE RANDOM CO-POLY(HYDROXYCARBONATE) | Cyclicor AB (SE) | 2025-10-29 | — | — | EP | claimed |
| WO-2024136734-A1 | BPA-FREE RANDOM CO-POLY(HYDROXYCARBONATE) | CYCLICOR AB (SE) | 2024-06-27 | — | — | WO | claimed |
| EP-0280232-B1 | MONOACETYLATION OF DIOLS USING A BIOCATALYST FROM CORYNEBACTERIUM OXYDANS | GENENCOR INTERNATIONAL, INC. (US) | 1993-02-10 | — | — | EP | claimed |
| EP-0280232-A2 | Monoacetylation of diols using a biocatalyst from corynebacterium oxydans | GENENCOR INTERNATIONAL, INC. (US) | 1988-08-31 | — | — | EP | claimed |
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-3994125-B1 | MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF | REGENERON PHARMA (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4638553-A1 | BPA-FREE RANDOM CO-POLY(HYDROXYCARBONATE) | Cyclicor AB (SE) | 2025-10-29 | — | — | EP | disclosed |
| US-20250257166-A1 | ETHYLENICALLY UNSATURATED POLY(PHTHALALDEHYDE) POLYMERS, COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2025-08-14 | — | — | US | disclosed |
| EP-3578578-B1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| US-20250163281-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4484465-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| CN-118749016-A | Thermoplastic resin composition for hot melt lamination molding, molded body, and method for producing the same | 株式会社ADEKA | 2024-10-08 | — | — | CN | disclosed |
| EP-0173041-B1 | 2-SUBSTITUTED-1,3-PROPYLIDENEDIPHOSPHONATE DERIVATIVES, THE PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SYMPHAR S.A. (CH) | 1988-11-30 | — | — | EP | disclosed |
| EP-0280232-A2 | Monoacetylation of diols using a biocatalyst from corynebacterium oxydans | GENENCOR INTERNATIONAL, INC. (US) | 1988-08-31 | — | — | EP | disclosed |
| US-4696920-A | CARDIOVASCULAR DISORDERS | SYMPHAR S.A. (CH) | 1987-09-29 | — | — | US | disclosed |
| EP-0173041-A1 | 2-Substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them | SYMPHAR S.A. (CH) | 1986-03-05 | — | — | EP | disclosed |
| EP-0050327-B1 | PHOSPHOLIPIDS THAT CONTAIN SULPHUR, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS | Roche Diagnostics GmbH (DE) | 1984-06-20 | — | — | EP | disclosed |
| US-4444766-A | ANTITUMOR | BOEHRINGER MANNHEIM GMBH (DE) | 1984-04-24 | — | — | US | disclosed |
| EP-0050327-A1 | Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds | Roche Diagnostics GmbH (DE) | 1982-04-28 | — | — | EP | disclosed |
| US-4109015-A | PROSTAGLANDINS, LUTEOLYTIC | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | TRPA1 3272/4885TSHR 4867/4885EPHX1 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.